Uscom Ltd has released a press release.
Uscom Receives $0.5M R&D Cash Refund
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from Uscom
- New BP Plus Patent
- Uscom BPplus Detects New Evidence of Cardiovascular Disease
- Uscom ends 2016 with record manufacturing
- Uscom Awarded Euro Grant for Lung Cancer Diagnostic
- CE Mark for New Uscom Asthma and COPD Devices
Later from Uscom
- China BP Plus and SpiroSonic Regulatory Submissions
- New USCOM Evidence for Preeclampsia
- New Uscom Euro Grant for Pulmonary Research
- Uscom Achieves First Cash Flow Positive Quarter
- Uscom Achieves First Cash Flow Positive Quarter Appendix 4C
Follow Uscom into a list and get an email when it puts out news.
Follow Uscom